scholarly journals Individual-Based Network Model for Rift Valley Fever in Kabale District, Uganda, to Guide Mitigation Measures: A One Health Model

2018 ◽  
Author(s):  
Musa Sekamatte ◽  
Mahbubul H. Riad ◽  
Tesfaalem Tekleghiorghis ◽  
Kenneth J. Linthicum ◽  
Seth C. Britch ◽  
...  
Keyword(s):  
Rift Valley ◽  
Rift Valley Fever ◽  
Mosquito Control ◽  
Rift Valley Fever Virus ◽  
Mitigation Strategies ◽  
Mitigation Measures ◽  
Valley Fever ◽  
Mosquito Abundance ◽  
Vector Mosquito ◽  
Kabale District

AbstractRift Valley fever (RVF) is a zoonotic disease which causes significant morbidity and mortality among ungulate livestock and humans in endemic regions. In the major RVF epizootic regions of East Africa, the causative agent of the disease, Rift Valley fever virus (RVFV), is primarily transmitted by multiple mosquito species in Aedes, Culex, and Mansonia genera during both epizootic and enzootic periods in a complex transmission cycle largely driven by the environment. However, recent RVFV activity in Uganda demonstrated that RVFV could also spread into new regions through livestock movements, and underscored the need to develop effective mitigation strategies to reduce transmission and prevent spread among cattle operations. We simulated RVFV transmission among cattle in different sub counties of Kabale District in Uganda using real world livestock data in a network-based model. This model considered livestock as spatially explicit factors in different sub-counties subjected to specific vector mosquito and environmental factors, and was configured to investigate and quantitatively evaluate the relative impacts of mosquito control, livestock movement regulations, and diversity in cattle populations on the spread of the RVF epizootic. We concluded that cattle movement should be restricted during periods of high vector mosquito abundance to control the epizootic spreading among sub-counties. On the other hand we found that mosquito control would only be sufficient to control the epizootic when mosquito abundance was low. Importantly, simulation results also showed that cattle populations with a higher diversity with regard to indigenous combined with exotic breeds led to reduced numbers of infected cattle compared to more homogenous cattle populations.

scholarly journals Quantitative Assessment of the Entry through Mechanical Transport in Aircraft of Rift Valley Fever Virus-Infected Mosquitoes into Previously Unaffected Areas

Pathogens ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 541
Author(s):  
Maria-Eleni Filippitzi ◽  
Claude Saegerman
Keyword(s):  
Rift Valley ◽  
Rift Valley Fever ◽  
Risk Mitigation ◽  
Rift Valley Fever Virus ◽  
Stochastic Approach ◽  
European Countries ◽  
Mitigation Measures ◽  
Health Concern ◽  
African Countries ◽  
Valley Fever

(1): Rift Valley Fever (RVF) is a zoonotic disease of significant international health concern and considered as an emerging risk to Europe, where no RVF outbreaks in humans or animals have been reported so far. (2): Using a stochastic approach, we estimated the risk of RVF virus (RVFV) introduction during the period of May to October (the period when mosquito populations, including RVFV potential vectors, are present in European countries), into previously unaffected areas (e.g., United Kingdom, UK) via virus-carrying vectors traveling in commercial aircraft from RVF-affected countries (e.g., East Africa); (3): On average N = 68 (95% CI: 0–337), RVF-virus-infected mosquitoes are estimated to be mechanically transported by planes (with N = 0 as most likely), in direct flights from RVF-affected East African countries to the UK, between May and October. This estimate is considered as low but not negligible. The model developed should be easily scaled up to other European countries by amending appropriately country-specific variables (e.g., number of flights between countries) in order to map the areas/airports of higher risk and inform risk management per country accordingly and to adopt risk-mitigation measures.

Complement fixation reaction of Rift Valley fever virus

1950 ◽  
Vol 5 (5) ◽  
pp. 243-247
Author(s):  
Minoru MATSUMOTO ◽  
Saburo IWASA ◽  
Motosige ENDO
Keyword(s):  
Rift Valley ◽  
Rift Valley Fever ◽  
Complement Fixation ◽  
Rift Valley Fever Virus ◽  
Fever Virus ◽  
Valley Fever ◽  
Fixation Reaction

scholarly journals The Use of Nanotrap Particles in the Enhanced Detection of Rift Valley Fever Virus Nucleoprotein

PLoS ONE ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. e0128215 ◽  
Author(s):  
Nazly Shafagati ◽  
Lindsay Lundberg ◽  
Alan Baer ◽  
Alexis Patanarut ◽  
Katherine Fite ◽  
...  
Keyword(s):  
Rift Valley ◽  
Rift Valley Fever ◽  
Rift Valley Fever Virus ◽  
Fever Virus ◽  
Valley Fever

scholarly journals Serological evidence of Rift Valley fever virus infection among domestic ruminant herds in Uganda

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Deo B. Ndumu ◽  
Barnabas Bakamutumaho ◽  
Edward Miller ◽  
Jesca Nakayima ◽  
Robert Downing ◽  
...  
Keyword(s):  
Rift Valley ◽  
Rift Valley Fever ◽  
Rift Valley Fever Virus ◽  
Northern Region ◽  
Western Region ◽  
Domestic Ruminant ◽  
The South ◽  
Valley Fever ◽  
Sheep And Goats ◽  
The Western Region

Abstract Background Prior to the first recorded outbreak of Rift Valley fever (RVF) in Uganda, in March 2016, earlier studies done until the 1970’s indicated the presence of the RVF virus (RVFV) in the country, without any recorded outbreaks in either man or animals. While severe outbreaks of RVF occurred in the neighboring countries, none were reported in Uganda despite forecasts that placed some parts of Uganda at similar risk. The Ministry of Agriculture, Animal Industry and Fisheries (MAAIF) undertook studies to determine the RVF sero-prevalence in risk prone areas. Three datasets from cattle sheep and goats were obtained; one from retrospective samples collected in 2010–2011 from the northern region; the second from the western region in 2013 while the third was from a cross-sectional survey done in 2016 in the south-western region. Laboratory analysis involved the use of the Enzyme Linked Immunosorbent Assays (ELISA). Data were subjected to descriptive statistical analyses, including non-parametric chi-square tests for comparisons between districts and species in the regions. Results During the Yellow Fever outbreak investigation of 2010–2011 in the northern region, a total sero-prevalence of 6.7% was obtained for anti RVFV reacting antibodies (IgG and IgM) among the domestic ruminant population. The 2013 sero-survey in the western region showed a prevalence of 18.6% in cattle and 2.3% in small ruminants. The 2016 sero-survey in the districts of Kabale, Kanungu, Kasese, Kisoro and Rubirizi, in the south-western region, had the respective district RVF sero-prevalence of 16.0, 2.1, 0.8, 15.1and 2.7% among the domestic ruminants combined for this region; bovines exhibited the highest cumulative sero-prevalence of 15.2%, compared to 5.3 and 4.0% respectively for sheep and goats per species for the region. Conclusions The absence of apparent outbreaks in Uganda, despite neighboring enzootic areas, having minimal restrictions to the exchange of livestock and their products across borders, suggest an unexpected RVF activity in the study areas that needs to be unraveled. Therefore, more in-depth studies are planned to mitigate the risk of an overt RVF outbreak in humans and animals as has occurred in neighboring countries.

scholarly journals Production of small ruminant morbillivirus, rift valley fever virus and lumpy skin disease virus in CelCradle™ -500A bioreactors

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Halima Rhazi ◽  
Najete Safini ◽  
Karima Mikou ◽  
Meryeme Alhyane ◽  
Khalid Omari Tadlaoui ◽  
...  
Keyword(s):  
Disease Virus ◽  
Skin Disease ◽  
Rift Valley ◽  
Rift Valley Fever ◽  
Rift Valley Fever Virus ◽  
Fever Virus ◽  
Valley Fever ◽  
Lumpy Skin Disease ◽  
Lumpy Skin Disease Virus ◽  
Cell Factories

Abstract Background Animal vaccination is an important way to stop the spread of diseases causing immense damage to livestock and economic losses and the potential transmission to humans. Therefore effective method for vaccine production using simple and inexpensive bioprocessing solutions is very essential. Conventional culture systems currently in use, tend to be uneconomic in terms of labor and time involved. Besides, they offer a limited surface area for growth of cells. In this study, the CelCradle™-500A was evaluated as an alternative to replace conventional culture systems in use such as Cell factories for the production of viral vaccines against small ruminant morbillivirus (PPR), rift valley fever virus (RVF) and lumpy skin disease virus (LSD). Results Two types of cells Vero and primary Lamb Testis cells were used to produce these viruses. The study was done in 2 phases as a) optimization of cell growth and b) virus cultivation. Vero cells could be grown to significantly higher cell densities of 3.04 × 109 using the CelCradle™-500A with a shorter doubling time as compared to 9.45 × 108 cells in Cell factories. This represents a 19 fold increase in cell numbers as compared to seeding vs only 3.7 fold in Cell factories. LT cells achieved modestly higher cell densities of 6.7 × 108 as compared to 6.3 × 108 in Cell factories. The fold change in densities for these cells was 3 fold in the CelCradle™-500A vs 2.5 fold in Cell factories. The titers in the conventional system and the bioreactor were not significantly different. However, the Cell-specific virus yield for rift valley fever virus and lumpy skin disease virus are higher (25 virions/cell for rift valley fever virus, and 21.9 virions/cell for lumpy skin disease virus versus 19.9 virions/cell for rift valley fever virus and 10 virions/cell for lumpy skin disease virus). Conclusions This work represents a novel study for primary lamb testis cell culture in CellCradle™-500A bioreactors. In addition, on account of the high cell densities obtained and the linear scalability the titers could be further optimized using other culture process such us perfusion.

Sign in / Sign up

Export Citation Format

Share Document